FDA Inspection
Biogen MA Inc.Biogen MA Inc. – FDA Inspection, Mar 23, 2017
Record Details
This FDA Inspection record concerns Biogen MA Inc., with an inspection on March 23, 2017, issued by the Center for Biologics Evaluation and Research, covering biologics.
View Company Profile
ID · 7be2ce18-c488-465d-ad5e-44bd30dc6af8
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1016280
- FDA center
- Biologics
- Project area
- Blood and Blood Products
- Outcome
- Form 483 issued
Other FDA inspections of Biogen MA Inc.
12| Date | Classification | Office | Project area |
|---|---|---|---|
| July 12, 2024 | NAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| February 15, 2019 | VAI | Center for Biologics Evaluation and Research | Blood and Blood Products |
| June 13, 2018 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| December 23, 2016 | Not classified | Atlanta District Office | |
| January 15, 2016 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Biogen MA Inc.
- FDA Inspection 1252412 - 2024-07-12
- FDA Inspection 1084879 - 2019-02-15
- FDA Inspection 1066958 - 2018-06-13
- FDA Inspection 999559 - 2016-12-23
- FDA Inspection 978930 - 2016-01-15
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.